Zobrazeno 1 - 10 of 43 pro vyhledávání: '"Larabi IA"'
1
Akademický článek
Target Organs of Metals Released from Metal-on-Polyethylene Knee and Hip Arthroplasty Implants: Implications for Tissue Metal Profiles.
Autor: Bellouard M; Department of Pharmacology and Toxicology, AP-HP, Raymond Poincaré Hospital, GHU AP-HP. Paris-Saclay, Garches, 92380, France. marie.martin@aphp.fr.; Saclay/Versailles University, CESP, Team MOODS, U-1018, Plateform MasSpecLab, 78180, Montigny-Le-Bretonneux, France. marie.martin@aphp.fr.; Laboratoire de Toxicologie, Hôpital Raymond Poincaré, 104 Bvd Raymond Poincaré, Garches, 92380, France. marie.martin@aphp.fr., de la GrandMaison GL; Department of Forensic Medicine and Pathology, AP-HP, Raymond Poincaré Hospital, Garches, 92380, France., Rambaud C; Department of Forensic Medicine and Pathology, AP-HP, Raymond Poincaré Hospital, Garches, 92380, France., Marmorat JL; Department of Traumatology and Orthopaedic Surgery, AP-HP, Raymond Poincaré Hospital, Garches, 92380, France., Grimaldi L; AP-HP, Ambroise Paré Hospital, Paris Ouest Research Clinic Unit, Boulogne-Billancourt, 92100, France., Nkam L; AP-HP, Ambroise Paré Hospital, Paris Ouest Research Clinic Unit, Boulogne-Billancourt, 92100, France., Larabi IA; Department of Pharmacology and Toxicology, AP-HP, Raymond Poincaré Hospital, GHU AP-HP. Paris-Saclay, Garches, 92380, France.; Saclay/Versailles University, CESP, Team MOODS, U-1018, Plateform MasSpecLab, 78180, Montigny-Le-Bretonneux, France., Alvarez JC; Department of Pharmacology and Toxicology, AP-HP, Raymond Poincaré Hospital, GHU AP-HP. Paris-Saclay, Garches, 92380, France.; Saclay/Versailles University, CESP, Team MOODS, U-1018, Plateform MasSpecLab, 78180, Montigny-Le-Bretonneux, France.
Publikováno v: Biological trace element research [Biol Trace Elem Res] 2024 Jun 28. Date of Electronic Publication: 2024 Jun 28.
Zobrazit plný text záznamu
2
Akademický článek
Body fluid contamination in the context of an adverse analytical finding in doping: About a case involving ostarine.
Autor: Alvarez JC; Department of Pharmacology and Toxicology, Raymond Poincaré Hospital, GHU AP-HP.Paris-Saclay, 92380 Garches, France; Paris-Saclay University, UVSQ, Inserm U-1018, CESP, Team MOODS, Plateform MasSpecLab, 78180 Montigny-le-Bretonneux, France. Electronic address: jean-claude.alvarez@aphp.fr., Etting I; Department of Pharmacology and Toxicology, Raymond Poincaré Hospital, GHU AP-HP.Paris-Saclay, 92380 Garches, France., Larabi IA; Department of Pharmacology and Toxicology, Raymond Poincaré Hospital, GHU AP-HP.Paris-Saclay, 92380 Garches, France; Paris-Saclay University, UVSQ, Inserm U-1018, CESP, Team MOODS, Plateform MasSpecLab, 78180 Montigny-le-Bretonneux, France.
Publikováno v: Clinica chimica acta; international journal of clinical chemistry [Clin Chim Acta] 2024 Apr 15; Vol. 557, pp. 117871. Date of Electronic Publication: 2024 Mar 11.
Zobrazit plný text záznamu
3
Akademický článek
Hair and dietary supplements testing to identify contamination with roxadustat in an adverse analytical finding.
Autor: Alvarez JC; Department of Pharmacology and Toxicology, Raymond Poincaré hospital, GHU AP-HP.Paris-Saclay, 92380 Garches, France; Paris-Saclay University, UVSQ, Inserm U-1018, Centre de Recherche en Épidémiologie et Santé des Populations (CESP), Team MOODS & Plateform MasSpecLab, 78180 Montigny-le-Bretonneux, France. Electronic address: jean-claude.alvarez@aphp.fr., Etting I; Department of Pharmacology and Toxicology, Raymond Poincaré hospital, GHU AP-HP.Paris-Saclay, 92380 Garches, France., Gheddar L; Institut de médecine légale, 11 rue Humann, 67000 Strasbourg, France., Kintz P; Institut de médecine légale, 11 rue Humann, 67000 Strasbourg, France., Larabi IA; Department of Pharmacology and Toxicology, Raymond Poincaré hospital, GHU AP-HP.Paris-Saclay, 92380 Garches, France; Paris-Saclay University, UVSQ, Inserm U-1018, Centre de Recherche en Épidémiologie et Santé des Populations (CESP), Team MOODS & Plateform MasSpecLab, 78180 Montigny-le-Bretonneux, France.
Publikováno v: Journal of pharmaceutical and biomedical analysis [J Pharm Biomed Anal] 2024 Feb 15; Vol. 239, pp. 115915. Date of Electronic Publication: 2023 Dec 11.
Zobrazit plný text záznamu
4
Akademický článek
Validation of Liquid Chromatography Coupled with Tandem Mass Spectrometry for the Determination of 12 Tyrosine Kinase Inhibitors (TKIs) and Their Application to Therapeutic Drug Monitoring in Adult and Pediatric Populations.
Autor: Bellouard M; Toxicology Laboratory, Raymond Poincaré Hospital, AP-HP, 92380 Garches, France.; Pediatric Hemato-Oncology Department, Trousseau Hospital, AP-HP, 75012 Paris, France., Donadieu J; Pediatric Hemato-Oncology Department, Trousseau Hospital, AP-HP, 75012 Paris, France., Thiebot P; Toxicology Laboratory, Lariboisière Hospital, AP-HP, 75010 Paris, France., Giroux Leprieur E; Pneumology Department, Ambroise Paré Hospital, AP-HP, 92100 Boulogne-Billancourt, France., Saiag P; Dermatology Department, Ambroise Paré Hospital, AP-HP, 92100 Boulogne-Billancourt, France., Etting I; Toxicology Laboratory, Raymond Poincaré Hospital, AP-HP, 92380 Garches, France., Dugues P; Toxicology Laboratory, Raymond Poincaré Hospital, AP-HP, 92380 Garches, France.; Inserm U-1018, CESP, Team MOODS, Plateform MasSpecLab, Paris-Saclay/Versailles University, 78180 Montigny-le-Bretonneux, France., Abe E; Toxicology Laboratory, Raymond Poincaré Hospital, AP-HP, 92380 Garches, France., Alvarez JC; Toxicology Laboratory, Raymond Poincaré Hospital, AP-HP, 92380 Garches, France.; Inserm U-1018, CESP, Team MOODS, Plateform MasSpecLab, Paris-Saclay/Versailles University, 78180 Montigny-le-Bretonneux, France., Larabi IA; Toxicology Laboratory, Raymond Poincaré Hospital, AP-HP, 92380 Garches, France.; Inserm U-1018, CESP, Team MOODS, Plateform MasSpecLab, Paris-Saclay/Versailles University, 78180 Montigny-le-Bretonneux, France.
Publikováno v: Pharmaceutics [Pharmaceutics] 2023 Dec 19; Vol. 16 (1). Date of Electronic Publication: 2023 Dec 19.
Zobrazit plný text záznamu
5
Akademický článek
Can inhaled cannabis users accurately evaluate impaired driving ability? A randomized controlled trial.
Autor: Hartley S; Sleep Unit, Physiology Department, AP-HP GHU Paris-Saclay, Raymond Poincaré Hospital, Garches, France., Simon N; Department of Clinical Pharmacology, Aix Marseille Univ, APHM, INSERM, IRD, SESSTIM, Hop Sainte Marguerite, CAP-TV, Marseille, France., Cardozo B; Department of Clinical Pharmacology, Aix Marseille Univ, APHM, INSERM, IRD, SESSTIM, Hop Sainte Marguerite, CAP-TV, Marseille, France., Larabi IA; Plateform MasSpecLab, Department of Pharmacology and Toxicology, Raymond Poincaré Hospital, GHU AP-HP.Paris-Saclay, Paris-Saclay University, UVSQ, Inserm U-1018, CESP, Team MOODS, Garches, France., Alvarez JC; Plateform MasSpecLab, Department of Pharmacology and Toxicology, Raymond Poincaré Hospital, GHU AP-HP.Paris-Saclay, Paris-Saclay University, UVSQ, Inserm U-1018, CESP, Team MOODS, Garches, France.
Publikováno v: Frontiers in public health [Front Public Health] 2023 Nov 22; Vol. 11, pp. 1234765. Date of Electronic Publication: 2023 Nov 22 (Print Publication: 2023).
Zobrazit plný text záznamu
6
Akademický článek
Study of the association between serum levels of kynurenine and cardiovascular outcomes and overall mortality in chronic kidney disease.
Autor: El Chamieh C; Centre for Research in Epidemiology and Population Health (CESP), INSERM UMRS 1018, Université Paris-Saclay, Université Versailles Saint Quentin, Villejuif, France., Larabi IA; Department of Pharmacology and Toxicology, Raymond Poincaré Hospital, AP-HP, Garches, France.; UVSQ, Université Paris-Saclay, Inserm U1018, CESP, Équipe MOODS, MasSpecLab, Montigny-le-Bretonneux, France., Alencar De Pinho N; Centre for Research in Epidemiology and Population Health (CESP), INSERM UMRS 1018, Université Paris-Saclay, Université Versailles Saint Quentin, Villejuif, France., Lambert O; Centre for Research in Epidemiology and Population Health (CESP), INSERM UMRS 1018, Université Paris-Saclay, Université Versailles Saint Quentin, Villejuif, France., Combe C; Service de Néphrologie Transplantation Dialyse Aphérèse, Centre Hospitalier Universitaire de Bordeaux, Bordeaux, France.; INSERM, U1026, University Bordeaux, Bordeaux, France., Fouque D; Nephrology Dept, Centre Hospitalier Lyon Sud, Université de Lyon, Carmen, Pierre-Bénite, France.; Université de Lyon, CarMeN INSERM 1060, Lyon, France., Frimat L; Nephrology Department, CHRU de Nancy, Vandoeuvre-lès-Nancy, France.; Lorraine University, APEMAC, Vandoeuvre-lès-Nancy, France., Jacquelinet C; Centre for Research in Epidemiology and Population Health (CESP), INSERM UMRS 1018, Université Paris-Saclay, Université Versailles Saint Quentin, Villejuif, France.; Biomedecine Agency, Saint Denis La Plaine, France., Laville M; Université de Lyon, CarMeN INSERM 1060, Lyon, France., Laville S; Pharmacoepidemiology Unit, Department of Clinical Pharmacology, Amiens-Picardie University Medical Center, Amiens, France.; MP3CV Laboratory, Jules Verne University of Picardie, Amiens, France., Lange C; Centre for Research in Epidemiology and Population Health (CESP), INSERM UMRS 1018, Université Paris-Saclay, Université Versailles Saint Quentin, Villejuif, France., Alvarez JC; Department of Pharmacology and Toxicology, Raymond Poincaré Hospital, AP-HP, Garches, France.; UVSQ, Université Paris-Saclay, Inserm U1018, CESP, Équipe MOODS, MasSpecLab, Montigny-le-Bretonneux, France., Massy ZA; Centre for Research in Epidemiology and Population Health (CESP), INSERM UMRS 1018, Université Paris-Saclay, Université Versailles Saint Quentin, Villejuif, France.; Department of Nephrology, Ambroise Paré University Hospital, APHP, Boulogne-Billancourt, France., Liabeuf S; Pharmacoepidemiology Unit, Department of Clinical Pharmacology, Amiens-Picardie University Medical Center, Amiens, France.; MP3CV Laboratory, Jules Verne University of Picardie, Amiens, France.
Publikováno v: Clinical kidney journal [Clin Kidney J] 2023 Sep 28; Vol. 17 (1), pp. sfad248. Date of Electronic Publication: 2023 Sep 28 (Print Publication: 2024).
Zobrazit plný text záznamu
7
Akademický článek
The duration of ketamine detection in hair after treatment cessation: Case study and review of the literature in forensic and clinical casework.
Autor: Larabi IA; Department of Pharmacology and Toxicology, Raymond Poincaré hospital, AP-HP, Garches, France.; Université Paris-Saclay, UVSQ, Inserm U1018, CESP, Équipe MOODS, Montigny-le-Bretonneux, France., Etting I; Department of Pharmacology and Toxicology, Raymond Poincaré hospital, AP-HP, Garches, France., Alvarez JC; Department of Pharmacology and Toxicology, Raymond Poincaré hospital, AP-HP, Garches, France.; Université Paris-Saclay, UVSQ, Inserm U1018, CESP, Équipe MOODS, Montigny-le-Bretonneux, France.
Publikováno v: Drug testing and analysis [Drug Test Anal] 2023 Sep; Vol. 15 (9), pp. 971-979. Date of Electronic Publication: 2023 Feb 14.
Zobrazit plný text záznamu
8
Akademický článek
Characterization of extensive 2-fluorodeschloroketamine metabolism in pooled human liver microsomes, urine and hair from an addicted patient using high-resolution accurate mass spectrometry.
Autor: Joseph D; Université Paris-Saclay, CNRS, BioCIS, Châtenay-Malabry 92290, France., Lesueur C; Department of Pharmacology and Toxicology, Raymond Poincaré Hospital, AP-HP, Garches 92380, France.; Université Paris-Saclay, UVSQ, Inserm U1018, CESP, Équipe MOODS, MasSpecLab, Montigny-le-Bretonneux 78180, France., Zerizer F; Department of Pharmacology and Toxicology, Raymond Poincaré Hospital, AP-HP, Garches 92380, France.; Université Paris-Saclay, UVSQ, Inserm U1018, CESP, Équipe MOODS, MasSpecLab, Montigny-le-Bretonneux 78180, France., Fenot A; Department of Pharmacology and Toxicology, Raymond Poincaré Hospital, AP-HP, Garches 92380, France.; Université Paris-Saclay, UVSQ, Inserm U1018, CESP, Équipe MOODS, MasSpecLab, Montigny-le-Bretonneux 78180, France., Alvarez JC; Department of Pharmacology and Toxicology, Raymond Poincaré Hospital, AP-HP, Garches 92380, France.; Université Paris-Saclay, UVSQ, Inserm U1018, CESP, Équipe MOODS, MasSpecLab, Montigny-le-Bretonneux 78180, France., Larabi IA; Department of Pharmacology and Toxicology, Raymond Poincaré Hospital, AP-HP, Garches 92380, France.; Université Paris-Saclay, UVSQ, Inserm U1018, CESP, Équipe MOODS, MasSpecLab, Montigny-le-Bretonneux 78180, France.
Publikováno v: Journal of analytical toxicology [J Anal Toxicol] 2023 Jul 22; Vol. 47 (6), pp. 504-516.
Zobrazit plný text záznamu
9
Akademický článek
First detection/quantification of roxadustat in hair with a new liquid chromatography with tandem mass spectrometry method: Application to a treated patient.
Autor: Alvarez JC; Department of Pharmacology and Toxicology, Raymond Poincaré hospital, GHU AP-HP.Paris-Saclay, 92380 Garches, France; Paris-Saclay University, UVSQ, Inserm U-1018, Centre de Recherche en Épidémiologie et Santé des Populations (CESP), Team MOODS & Plateform MasSpecLab, 78180 Montigny-le-Bretonneux, France. Electronic address: jean-claude.alvarez@aphp.fr., Etting I; Department of Pharmacology and Toxicology, Raymond Poincaré hospital, GHU AP-HP.Paris-Saclay, 92380 Garches, France., Juillard L; Department of Nephrology, CHU E Herriot, 69003 Lyon Cedex, France; CarMeN lab, INSA-Lyon, INSERM U1060, INRA, Claude Bernard University Lyon 1, F-69621 Villeurbanne, France., Massy Z; Department of Nephrology, CHU Ambroise Paré, GHU AP-HP.Paris-Saclay, 92104 Boulogne Billancourt Cedex, France; Paris-Saclay University, UVSQ, Inserm U-1018, Centre de Recherche en Épidémiologie et Santé des Populations (CESP), Team 5, Villejuif, France., Larabi IA; Department of Pharmacology and Toxicology, Raymond Poincaré hospital, GHU AP-HP.Paris-Saclay, 92380 Garches, France; Paris-Saclay University, UVSQ, Inserm U-1018, Centre de Recherche en Épidémiologie et Santé des Populations (CESP), Team MOODS & Plateform MasSpecLab, 78180 Montigny-le-Bretonneux, France.
Publikováno v: Clinica chimica acta; international journal of clinical chemistry [Clin Chim Acta] 2023 Jun 01; Vol. 546, pp. 117395. Date of Electronic Publication: 2023 May 19.
Zobrazit plný text záznamu
10
Akademický článek
Proton-Pump Inhibitors and Serum Concentrations of Uremic Toxins in Patients with Chronic Kidney Disease.
Autor: El Chamieh C; Centre for Research in Epidemiology and Population Health (CESP), INSERM UMRS 1018, Université Paris-Saclay, Université Versailles Saint Quentin, 94807 Villejuif, France., Larabi IA; Department of Pharmacology and Toxicology, Raymond Poincaré Hospital, AP-HP, 92380 Garches, France.; UVSQ, Université Paris-Saclay, Inserm U1018, CESP, Équipe MOODS, MasSpecLab, 78180 Montigny-le-Bretonneux, France., Laville SM; Pharmacoepidemiology Unit, Department of Clinical Pharmacology, Amiens-Picardie University Medical Center, 80054 Amiens, France.; MP3CV Laboratory, Jules Verne University of Picardie, F-80054 Amiens, France., Jacquelinet C; Centre for Research in Epidemiology and Population Health (CESP), INSERM UMRS 1018, Université Paris-Saclay, Université Versailles Saint Quentin, 94807 Villejuif, France.; Biomedecine Agency, 93210 Saint Denis La Plaine, France., Combe C; Service de Néphrologie Transplantation Dialyse Aphérèse, Centre Hospitalier Universitaire de Bordeaux, 33076 Bordeaux, France.; INSERM, U1026, Univ. Bordeaux, 33076 Bordeaux, France., Fouque D; Nephrology Department, Centre Hospitalier Lyon Sud, Université de Lyon, Carmen, 69495 Pierre-Bénite, France.; Université de Lyon, CarMeN INSERM 1060, 69008 Lyon, France., Laville M; Université de Lyon, CarMeN INSERM 1060, 69008 Lyon, France., Frimat L; Nephrology Department, CHRU de Nancy, 54000 Vandoeuvre-lès-Nancy, France.; Lorraine University, APEMAC, 54000 Vandoeuvre-lès-Nancy, France., Pecoits-Filho R; Arbor Research Collaborative for Health, Ann Arbor, MI 48108, USA.; School of Medicine, Pontificia Universidade Catolica do Parana, Curitiba 80215-901, Brazil., Lange C; Centre for Research in Epidemiology and Population Health (CESP), INSERM UMRS 1018, Université Paris-Saclay, Université Versailles Saint Quentin, 94807 Villejuif, France., Stengel B; Centre for Research in Epidemiology and Population Health (CESP), INSERM UMRS 1018, Université Paris-Saclay, Université Versailles Saint Quentin, 94807 Villejuif, France., Alencar De Pinho N; Centre for Research in Epidemiology and Population Health (CESP), INSERM UMRS 1018, Université Paris-Saclay, Université Versailles Saint Quentin, 94807 Villejuif, France., Alvarez JC; Department of Pharmacology and Toxicology, Raymond Poincaré Hospital, AP-HP, 92380 Garches, France.; UVSQ, Université Paris-Saclay, Inserm U1018, CESP, Équipe MOODS, MasSpecLab, 78180 Montigny-le-Bretonneux, France., Massy ZA; Centre for Research in Epidemiology and Population Health (CESP), INSERM UMRS 1018, Université Paris-Saclay, Université Versailles Saint Quentin, 94807 Villejuif, France.; Department of Nephrology, Ambroise Paré University Hospital, APHP, 92104 Boulogne-Billancourt, France., Liabeuf S; Pharmacoepidemiology Unit, Department of Clinical Pharmacology, Amiens-Picardie University Medical Center, 80054 Amiens, France.; MP3CV Laboratory, Jules Verne University of Picardie, F-80054 Amiens, France.
Publikováno v: Toxins [Toxins (Basel)] 2023 Apr 07; Vol. 15 (4). Date of Electronic Publication: 2023 Apr 07.
Zobrazit plný text záznamu

Vyhledávací nástroje:

Upřesnit hledání

Omezení vyhledávání
Plný text Recenzováno Digitální knihovna AV ČR
Zdroje